Molecule Structure

Scientific Name

Nafcillin

Description of the Drug

Nafcillin is a penicillin derivative antibiotic used to treat susceptible staphylococcal infections.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00607

Brand Name(s)

Not Available

Company Owner(s)

Wytells Pharma Private Ltd, Wyeth Ayerst Laboratories, Steriscience Pte Ltd, Glaxosmithkline, Apothecon Inc Div Bristol Myers Squibb, Sagent Pharmaceuticals Inc, Sandoz Inc, Istituto Biochimico Italiano Spa, Watson Laboratories Inc, Fresenius Kabi Ipsum Srl

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Penicillin-binding protein PROTEIN FAMILY INHIBITOR CHEMBL2362972

Unichem Links

SureChEMBL SCHEMBL47797
PharmGKB PA450576
Human Metabolome Database HMDB0014745
DrugBank DB00607
PubChem: Thomson Pharma 14929045
PubChem 8982
LINCS LSM-2402
Nikkaji J10.134F
BindingDB 50103525
EPA CompTox Dashboard DTXSID8023343
DrugCentral 1869
ChemicalBook CB9914919
Guide to Pharmacology 10942
rxnorm NAFCILLIN SODIUM NAFCILLIN NAFCILLIN SODIUM MONOHYDRATE
KEGG Ligand C07250
ChEBI 7447
ZINC ZINC000003875980